iBio
IBIO
IBIO
46 hedge funds and large institutions have $4.97M invested in iBio in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 15 closing their positions.
Holders
46
Holders Change
-11
Holders Change %
-19.3%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
13
Closed
15
Calls
$85K
Puts
$73K
Net Calls
+$12K
Net Calls Change
-$21K
Top Buyers
| 1 |
1
BlackRock
New York
|
$1.16M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.02M |
| 3 |
N
3
Natixis
Paris,
France
|
$33K |
| 4 |
4
Charles Schwab
San Francisco,
California
|
$31K |
| 5 |
5
Renaissance Technologies
New York
|
$219K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$414K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$33K |
| 3 |
3
Goldman Sachs
New York
|
$0 |
| 4 |
4
Morgan Stanley
New York
|
$11K |
| 5 |
E
5
Ergoteles
New York
|
$142K |
